Presentation Impact of Wait Times on the Effectiveness of TAVR in Severe Aortic Valve Disease Presenter: Harindra C. Wijeysundera June 09, 2014
Presentation Early Regression of Severe LV Hypertrophy After TAVR Is Associated with Decreased Hospitalizations Presenter: Brian R. Lindman June 25, 2014
Presentation PREVAIL: Prospective Randomized Evaluation of the Watchman LAA Closure Device in Patients with A-fib vs Long-term Warfarin Therapy Presenter: David R. Holmes Jr. June 30, 2014
Presentation Three-Year Outcomes after TAVR with the CoreValve Prosthesis Presenter: Michael Gotzmann June 30, 2014
Presentation CTO 2013 Case 9: Complex Left Main with Multivessel Disease: Technical Approach and Role of Staging Presenter: Antonio Colombo February 22, 2013
Presentation ACC 2013 Strategies of Clopidogrel Load and Atorvastatin Reload to Prevent Ischemic Cerebral Events in Patients Undergoing Protected Carotid Stenting: Results from the Randomized ARMYDA-9 CAROTID Study Presenter: Giuseppe Patti March 08, 2013
Presentation ACC 2013 The Repositionable Lotus Aortic Valve Replacement System: Six-Month Outcomes in the REPRISE I Feasibility Study Presenter: Ian T. Meredith March 11, 2013